Spotlight
Video

Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS

Loading........
Description: Marlise R. Luskin, MD, MSCE, Johns Hopkins University School of Medicine, discusses Awaiting Phase 3 for Luspatercept and ASTX727 Clinical trial accrual is an ongoing challenge in MDS at Imedex Great Debates 2018.
Shared By : hematologydebates
Posted on : 04/19/18
Added : 1 year ago



Recommended

Nothing found.